601 kinds of drugs to be priced by the market, OTC prices to be fully liberalized?

Source: sabilan 2014-10-23 China and drug price reform are being pushed to the top of the wave due to the corruption related storm in the price department of the national development and Reform Commission At this time, Jiangxi Province took the lead in implementing a breakthrough reform in drug price management on October 22, liberalizing the prices of all 601 over-the-counter drugs under the control of Jiangxi Province, leaving them to enterprises for independent pricing This can be said to be a landmark measure of China's drug price reform in recent years, which has torn open a gap between the government's formulation of drug prices and its unwillingness to let go It is a concrete manifestation of the government's reduction of government power and its decentralization and its return to the market 601 kinds of drugs were handed over to the market for pricing According to fan Wenjuan, a reporter from China news network, Jiangxi Provincial Development and Reform Commission held a press conference on the same day to release the provincial "opinions on further deepening price management reform" (hereinafter referred to as "opinions") According to the opinion, the government took the lead in liberalizing the prices of all 601 kinds of over-the-counter drugs under provincial control, liberalizing the prices of services and encouraging the public to run medicine and education In terms of drug pricing, Jiangxi took the lead in liberalizing the prices of all 601 kinds of over-the-counter drugs under provincial control After the opening up, the provincial price authorities will no longer set the maximum retail price for the over-the-counter drugs with the original provincial price control The drug production and marketing enterprises will participate in the market competition and the survival of the fittest will be eliminated According to the market demand, the enterprises will set their own prices At the same time, we will open up service prices and encourage the public to run medical and educational services After liberalizing the medical service prices of non-public medical institutions, private education fees, part-time graduate education, adult education and self-study education fees, these institutions can set their own prices according to the market supply and demand and competition, in accordance with the principles of fairness, legality and good faith, and maintain a relatively stable price level within a certain period of time, and the government does not intervene improperly In fact, as early as April this year, Jiangxi Province announced that the prices of 601 over-the-counter drugs had been fully liberalized, but no official documents had been seen The issue of the opinions is a formal confirmation According to the official website of Jiangxi Provincial Development and Reform Commission, ye Baiqing, deputy director of Jiangxi Provincial Development and Reform Commission and director of Jiangxi Provincial Price Bureau, said at the conference that price is the core of the market and the most sensitive, direct and effective means and tools to guide resource allocation The decisive role of market in allocating resources depends on the establishment of a reasonable price mechanism Jiangxi Province will complete the task of price reform in an all-round way by 2020 (strive to achieve the goal by 2018), and form a price control mechanism that is mainly determined by the market and supervised by the government One of the six characteristics of Jiangxi price reform is "reduction" It is mainly to further simplify administration and delegate power, significantly reduce government pricing projects, hand over to the market all that can be priced by the market, and implement independent pricing by enterprises The second is "release" Mainly for the reserved price approval items, if it is more convenient and effective to be approved by the local price competent department, all the items should be decentralized as far as possible, and the provincial medical service price authority should be delegated to the pilot city of public hospital reform Third, reform It is mainly to improve and perfect the government pricing method, standardize the government pricing behavior, and give full play to the role of "the government's hand" The opinion further clarifies a series of system requirements and measures, such as cost investigation, cost supervision, price cost demonstration, expert review, expert demonstration, price hearing, etc Fourth, promote It is mainly to give full play to the leverage effect of price and promote the adjustment of industrial structure Fifth, construction It is mainly to establish and improve the price regulation system and supervision system, and further improve the level of price regulation, including the formulation of price regulation policies, the collection and use of price regulation funds, price monitoring and early warning system, etc In particular, it is proposed to establish a strong anti price monopoly law enforcement agency, strengthen the investigation and punishment of price monopoly, and maintain and promote fair competition Six is "guarantee" It is mainly to protect people's livelihood and try to resolve the impact of price adjustment on the basic life of low-income residents Ye Baiqing said that the opinion is an important document guiding Jiangxi Province to deepen the reform of price management at present and in the future, marking the start of a new round of deepening the reform of price management in an all-round way A few days ago, relevant personnel of the price department of the national development and Reform Commission disclosed that although some personnel of the Department were investigated, the drug price reform still needs to be further promoted Within a few days, the breakthrough drug price reform in Jiangxi province came to the surface In late July, some media said that they learned from the China over the counter drug association that the national development and Reform Commission had drafted a draft for comments, intended to liberalize the prices of over-the-counter drugs, non-medical insurance catalogue and other drugs, implement market regulation and allow enterprises to set their own prices It is reported that the scope of drug price liberalization includes China's material patent drugs out of the medical insurance catalog, blood products out of the medical insurance catalog, over-the-counter drugs in the medical insurance catalog sold by retail pharmacies, drug dosage forms not reimbursed under the general name of traditional Chinese medicine in the medical insurance catalog, family planning drugs purchased by the state and vaccines under the national immunization program.